COVID-19 five years later: The impact on drug discovery
COVID-19 not only advanced scientific boundaries, but also transformed research methodologies and accelerated adaptive clinical trial design....
COVID-19 not only advanced scientific boundaries, but also transformed research methodologies and accelerated adaptive clinical trial design....
It's much more than just dexamethasone works, hydroxychloroquine doesn't....
Keeping the networks "warm" will lead to a faster response in the next pandemic, experts say....
There could be a combined Covid-19 and flu shot in our future, although it won’t be ready for this year’s flu season....
Amidst one of the greatest global health crises in over 100 years, national decentralized clinical trials (DCTs) organizations hit the industry like a storm....
Drug trial results show that vaccines aren’t the only use for the mRNA technology behind the most widely used COVID-19 jabs....
With key long COVID trials yet to yield results, people with the condition are trying to change how clinical trials are done....
Georgia Institute of Technology Scientists, in collaboration with investigators from University of Wisconsin—Madison as well as University of Tokyo continued pursuing the optimal coronavirus vaccine since the Covid-19 pandemic started....
Researchers at the University of Wisconsin School of Medicine and Public Health are exploring the ideal vaccine booster strategy for immunosuppressed patients to protect those at higher risk of severe illness and complications from COVID-19 infection....
The COVID-19 pandemic opened the door for some significant and noteworthy changes to the way our industry could accomplish clinical trials with a forced mandate to decentralize access and services for the continuation of studies....